Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVIBACTAM\CEFTAZIDIME: 1,655 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
1,655
Total FAERS Reports
567 (34.3%)
Deaths Reported
515
Hospitalizations
1,655
As Primary/Secondary Suspect
155
Life-Threatening
28
Disabilities

Active Ingredient: AVIBACTAM SODIUM\CEFTAZIDIME ·

First Report: 20140205 · Latest Report: 20250822

What Are the Most Common AVIBACTAM\CEFTAZIDIME Side Effects?

#1 Most Reported
Off label use
286 reports (17.3%)
#2 Most Reported
Drug ineffective
194 reports (11.7%)
#3 Most Reported
Death
187 reports (11.3%)

All AVIBACTAM\CEFTAZIDIME Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Off label use 286 17.3% 103 93
Drug ineffective 194 11.7% 101 73
Death 187 11.3% 187 11
Pathogen resistance 119 7.2% 34 42
Drug resistance 111 6.7% 42 48
Multiple organ dysfunction syndrome 74 4.5% 66 22
Septic shock 74 4.5% 62 37
Acute kidney injury 70 4.2% 16 24
Pyrexia 66 4.0% 19 37
Condition aggravated 62 3.8% 23 37
Treatment failure 51 3.1% 42 24
Sepsis 47 2.8% 23 22
Respiratory failure 46 2.8% 37 26
Diarrhoea 40 2.4% 16 26
Encephalopathy 40 2.4% 25 11
Platelet count decreased 37 2.2% 6 8
Myoclonus 36 2.2% 21 3
Pneumonia 36 2.2% 16 14
Renal failure 35 2.1% 10 19
Thrombocytopenia 34 2.1% 5 18

Who Reports AVIBACTAM\CEFTAZIDIME Side Effects? Age & Gender Data

Gender: 35.4% female, 64.6% male. Average age: 56.8 years. Most reports from: CN. View detailed demographics →

Is AVIBACTAM\CEFTAZIDIME Getting Safer? Reports by Year

YearReportsDeathsHosp.
2014 5 0 2
2015 17 1 8
2016 14 2 1
2017 20 13 5
2018 75 36 33
2019 91 26 40
2020 88 21 38
2021 100 37 24
2022 113 17 47
2023 96 12 37
2024 110 13 54
2025 75 22 28

View full timeline →

What Is AVIBACTAM\CEFTAZIDIME Used For?

IndicationReports
Product used for unknown indication 373
Pneumonia 173
Klebsiella infection 152
Pseudomonas infection 104
Infection 82
Sepsis 75
Abdominal infection 65
Anti-infective therapy 64
Pneumonia klebsiella 57
Bacterial infection 39

AVIBACTAM\CEFTAZIDIME vs Alternatives: Which Is Safer?

AVIBACTAM\CEFTAZIDIME vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE\TITANIUM DIOXIDE\ZINC AVIBACTAM\CEFTAZIDIME vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE AVIBACTAM\CEFTAZIDIME vs AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE AVIBACTAM\CEFTAZIDIME vs AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE OR AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE AVIBACTAM\CEFTAZIDIME vs AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE AVIBACTAM\CEFTAZIDIME vs AVOBENZONE\OCTINOXATE\OCTISALATE\OXYBENZONE AVIBACTAM\CEFTAZIDIME vs AVOBENZONE\OCTISALATE\OCTOCRYLENE AVIBACTAM\CEFTAZIDIME vs AVOBENZONE\OCTOCRYLENE\OXYBENZONE AVIBACTAM\CEFTAZIDIME vs AVONEX AVIBACTAM\CEFTAZIDIME vs AXICABTAGENE CILOLEUCEL

Official FDA Label for AVIBACTAM\CEFTAZIDIME

Official prescribing information from the FDA-approved drug label.